Find a Viewpoint

Antimicrobial Viewpoints are articles in which experts in different areas of antimicrobial resistance share their knowledge and opinions about the current status and the future challenges of this field. You can read our editorial and ethics policies for these articles here

<br>The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly approved antibiotics</br><em> – by Benedikt Huttner, Lorenzo Moja & Mike Sharland </em>
13 December 2023

The end of the pipeline is dry: major gaps in the clinical evidence required to inform clinical and country-level appraisal and use of newly ...

more
<br>Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs</br><em> – by Christoph M. Tang, Ann Jerse, Martin C. J. Maiden and William M. Shafer </em>
6 December 2023

Plasmid-mediated resistance in the gonococcus and the use of post-exposure prophylaxis to prevent bacterial STIs – by Christoph M. Tang, ...

more
<br>Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development </br><em> – by Tina Guina and Edward A. Weinstein </em>
29 November 2023

Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein ...

more
<br>Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope</br><em> – by Jacob Madden, Timo Minssen & Aaron S. Kesselheim </em>
27 September 2023

Putting the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act under the microscope – by Jacob Madden, Timo ...

more
<br>The emerging field of digital antibiotic discovery</br><em> – by Shuangzhe Lin & César de la Fuente</em>
16 August 2023

The emerging field of digital antibiotic discovery – by Shuangzhe Lin & César de la Fuente

more
<br>Market stimulation needed for predictable supply of antibiotics with vulnerable supply chains in Europe</br><em> – by Christine Årdal</em>
10 May 2023

Market stimulation needed for predictable supply of antibiotics with vulnerable supply chains in Europe – by Christine Årdal

more

Share

FacebookTwitterLinkedInEmail
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top